The Inam Butt Case: A Late Therapeutic Use Exemption and How the Rulebook Blows Its Whistle off the Mat

There is a moment in every hearing that no camera ever captures: the instant an athlete places a stack of medical records on the table and waits as someone flips through the pages. For Inam Butt — the former beach wrestling world champion from Pakistan — that moment stretched from April into early autumn, when his eye-treatment prescription became the center of an anti-doping investigation run by the International Testing Agency (ITA). What made me stop was not the sanction. What made me stop was the way the story is being told: as good news, as relief in sight, when behind the headline sits a silver medal waiting to be stripped, and a man who is simultaneously an athlete, a national squad coach, and a federation secretary, voluntarily stepping down while awaiting a ruling. I have stood in the place where every decision must be made in a split second. This time I stand elsewhere: re-reading the rulebook, checking every timestamp, and asking whether what is being called lenient is truly lenient. CONTEXT: TWO WORLDS MEET To understand the case, you have to understand two worlds colliding here. The first is beach wrestling — a discipline governed by United World Wrestling (UWW), younger and with a narrower competitive pyramid than Olympic freestyle or Greco-Roman. A world title here carries real weight, but fewer athletes sit at the top, and the opportunities for a nation to appear on the map are more concentrated. For Pakistan — a country where wrestling has deep cultural standing — a continental medal is spiritual property, not merely a personal achievement. The second world is the global anti-doping system. At this layer, the decision-maker is not the national federation but the ITA, a testing body operating under WADA's World Anti-Doping Code. When a case lands in the ITA's hands, it leaves the space of domestic public pressure and enters the space of procedure: sample collection, substance tracing, comparison against the prohibited list, and most importantly — the question of the Therapeutic Use Exemption (TUE). That is where the case becomes interesting. What is being judged is not a lock, not a takedown, but a piece of paper. The TUE is a concept the general audience rarely touches, yet it is one of the most intricate mechanisms in modern sport. In principle, an athlete with a medical condition requiring a prohibited substance may still compete — provided he applies in advance, proves the medical need is legitimate, and proves the substance does not deliver a performance benefit beyond what is necessary. This principle honors a human being's right to treatment. But it comes with a harsh clause: timing. The TUE must come first. And it is precisely that gap — not the use of the medication itself — where the Inam Butt case is anchored. In the reported file, the ITA accepted that the substance Butt used was for eye treatment, not performance enhancement. That is a key finding, because it separates the case from deliberate cheating. Yet the same file records that he failed to secure the necessary TUE before the testing point. At the level of law, these two facts do not cancel each other. They coexist: medication taken for a sound medical reason, but a procedural obligation breached. And the silver medal from the April Asian Beach Games — the most concrete sporting achievement in the story — sits inside the zone of strict liability. Meaning: even if you are innocent in intent, you can still lose the medal. This is where public emotion and legal logic diverge most sharply. CORE ANALYSIS: READING THE LAW LIKE READING A FIGHT If we treat the case as a fight, it is a fight between two sides not standing on the same mat: an athlete with a medical file, and a system with a rulebook. The referee does not blow the whistle for physical contact; the referee blows for a timeline. Let us split the case into layers, the way I split a contested moment into camera angles. The first layer is the nature of the substance. In any doping case, the first question is always: which category does this belong to? A strictly prohibited substance, or one prohibited in competition? A non-specified substance, or a specified one? This distinction determines the entire penalty framework. Common therapeutic medications — including many eye drops, anti-inflammatories, or treatments for chronic conditions — often fall into the specified category, and that category opens the door to reduced sanctions when the athlete proves the purpose was not cheating. In the Inam Butt file, the specific substance is not named, but the eye-treatment context and the ITA's acceptance of the medical explanation are two signals that it most likely belongs to the specified group. I stress most likely, because this is inference from context, not a published fact. The second layer is the degree of fault. The World Anti-Doping Code distinguishes sharply between no fault, no significant fault, and ordinary fault. These three levels lead to three different sanction zones. No fault means full exoneration. No significant fault means a substantially shortened ban. Ordinary fault means the full sanction, usually from several months to several years depending on the substance and the number of violations. In this case, the way the ITA handled it — per what has been reported — leans toward the no-significant-fault zone, not full exoneration. This is a crucial detail the relief headline usually obscures. The third layer, and this is the one I care about most as a former whistle-holder, is timing. The sanction is said to be backdated to April — coinciding with the April Asian Beach Games. In adjudication practice, backdating a sanction to the exact moment of the infraction is not a meaningless administrative detail. It is a signal that the panel accepted the athlete's timeline, that it found no sign of prolonged concealment, and that the entire span from that point to the decision has been counted as time served. In other words, what the press calls a two-month sanction may effectively be a sanction almost fully served by the time it is announced. This is where audiences easily misread. A two-month sanction backdated to April, announced in autumn, means the athlete may only need to sit out a very short additional period. But it is still an established doping case. It still leaves a line in the record. And it still carries a consequence no sanction can erase: the forfeiture of the medal. The fourth layer is the meaning of medal forfeiture. In the anti-doping system, medal stripping operates on strict liability. Once a sample is confirmed positive for a substance prohibited in competition, the competitive result tied to that sample is by default annulled — regardless of motive. This is different from a suspension, which can be reduced based on the degree of fault. Medals have no leniency zone. This is why a case can be described as lenient in sanction yet remain a permanent loss in achievement. If I had to place the case on a scorecard, the way I score a fight, I would use three criteria. First: procedural consistency. Here the case was delegated to the ITA, meaning a centralized, expert process. That is good for consistency, but it also means the outcome is hard to bend under national pressure — a plus for integrity, though not a plus for domestic fan emotion. Second: evidentiary transparency. This is the minus. The key details — the ITA's acceptance and the expected sanction — come from unnamed sources, not yet confirmed by an official decision. Based on my experience tracking similar cases, I always keep a question mark until the final document appears. In this article, I hold the same line: this is analysis, not a final verdict. Third: proportionality between fault and punishment. If the sanction is indeed about two months and backdated, then technically, under the law, that is a reasonable outcome for a no-significant-fault case. But remember that proportionality is not measured by the number of months alone. It is measured by total damage: the suspension, the stripped medal, the reputational wound, and — in this case — the affected administrative posts. And this is where I step off the technical mat to look at the sidelines, where Inam Butt stands wearing three hats. The file shows he is both a veteran athlete and a national squad coach, holding the post of national wrestling federation secretary and chairing the national Olympic committee's athletes commission. Four roles, one person. In small federations, this is so common it is nearly a rule: thin human resources force capable, respected people into multiple roles at once. It is efficient in normal operation and becomes a structural risk the moment a conflict of interest appears. A doping investigation against the very person holding administrative posts is the clearest form of conflict. The decision-maker and the subject cannot inhabit the same ecosystem without raising suspicion. So voluntarily stepping down from the federation secretary post and the athletes-commission chair while awaiting a ruling is a correct governance move. It does not prove innocence. It only shows the person understands that while the process runs, holding power is untenable. From the perspective of someone who has watched referee disputes, this deserves credit: an official proactively separating himself from a position that could invite suspicion, before being asked. That is rare behavior, and it sets this case apart from those where the people involved cling to their seats until the final minute. But I will not stop there. Because if I only praise the voluntary resignation, I would skip the harder question: why did a system allow one person to hold both an athlete role and an administrative role at such a sensitive moment? That is a question about design, not about an individual. CONTRARIAN ANGLE: WHAT NO ONE SEES This is the section I wrote most slowly, because it runs against how the story is being told. The popular telling is this: an athlete with an eye condition, taking medication, missing the paperwork, now treated lightly. That story is easy to hear. It makes all parties comfortable: the athlete is sympathized with, the federation keeps its prestige, and the anti-doping system appears humane. But there is one detail in the file I cannot ignore: a contradiction between two coexisting pieces of information. On one hand, the report says Butt failed to obtain the TUE in time. On the other, it says the ITA permitted the medication for a one-year period. These two cannot both be literally true unless that permission covered a different window or substance, or was granted retroactively. To me, this is not a small reporting error. It is the unresolved crux of the entire case. Because if the TUE was granted retroactively for a one-year span, the whole story changes in nature: it is no longer a prolonged procedural lapse but a recognized medical need and a paperwork gap that was filled. Conversely, if the TUE was only granted after detection, the case reflects a much larger systemic problem: that many athletes — especially in countries with thin medical and sports-law infrastructure — have no clear process for managing a chronic condition within the anti-doping framework. They are not cheating. They simply lack the right guidance. And this is my contrarian point: the most worrying thing in this case is not the punishment. It is that the case allows a system to punish and congratulate itself for being humane at the same time. An athlete still loses a medal, still carries a lifelong line in the record, still has to leave administrative posts — while the message sent to the public is that it went easy. I have stood long enough in the decision seat to know that procedural leniency does not equal leniency in consequence. A short suspension is still a suspension. A stripped medal is still a gap on the shelf. And an athlete named in a doping case — however sympathized with — still enters the rest of his career with a keyword attached to his name. There is one more dimension I want to say plainly, because I have witnessed something similar in referee disputes: when a decision is framed as lenient, fans tend to believe justice was done with mercy. But the real question is not mercy versus severity. The real question is whether the answer is structurally sufficient to prevent recurrence. If one athlete is punished for late paperwork, then every other athlete in the same situation — same condition, same thin medical infrastructure — carries the same risk. Unless there is a proactive support mechanism, the Inam Butt case will not be an exception. It will be a pattern. TAKEAWAY: WHAT THE LAW CANNOT WHISTLE When a fight ends, the referee leaves the mat and no one argues anymore about what he did. But cases like this do not end that way. They leave an open question for the whole system: can a paradox condemn and embrace the same person without eroding the only thing that makes sport work — the belief that every athlete is judged by the same measure. What I want to see after this case is not a harsher or lighter sanction. What I want to see is TUE training for athletes in countries with thin anti-doping infrastructure, and a clearer separation between the competing role and the administrative role. Because if the law does not blow its whistle at the exact moment the papers are received, it will blow earlier somewhere else — and next time, the one it blows in the face of may not be a former world champion with enough standing to step down on his own, but a young athlete with nothing to lose except the only chance of his life. The question I leave behind is not for Inam Butt, but for the system: if a late-filled form can strip a champion of his medal, who is holding the pen to make sure that form arrives in time for those without a voice?